CIK 0001818844 · Non-accelerated filer<br>Smaller reporting company
Dogwood Therapeutics, Inc.
Sign in to watch- Ticker
- DWTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 854314201
- Phone
- 8666208655
- Business address
- 44 MILTON AVENUE, ALPHARETTA, GA, 30009
- Former names
- Virios Therapeutics, Inc., Virios Therapeutics, LLC
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- DEF 14A Proxy Proxy Statement
- 4 Open-market buy Director bought 600 shares at $4.94 ($2,964)
- 4 Open-market buy Director bought 2,197 shares at $5.46 ($12,002)
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- 10-K Report Annual Report
- 8-K Event Results of operations
- 8-K Event Regulation FD disclosure
- 5 Insider Annual Insider Trading Report
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 4 Open-market buy Director bought 4,180 shares at $5.98 ($24,998)
- 4 Open-market buy Director bought 4,000 shares at $5.90 ($23,584)
- 4 Open-market buy Director bought 1,800 shares at $5.72 ($10,296)
- 4 Open-market buy Director bought 5,000 shares at $5.80 ($28,975)
- 4 Open-market buy Director bought 2,215 shares at $5.43 ($12,034)
Page 12 of 17 · 331 filings